Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Asano

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patientsTakashi Oyama, Kazuhito Yamamoto, Naoko Asano, et al.
Annals of Hematology|April 20, 2019
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal originMotoko Yamaguchi, Ritsuro Suzuki, Kana Miyazaki, et al.
Cancer|April 9, 2026
Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patientsKazutaka Suzuki, Kana Miyazaki, Naoko Asano, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Cancer Science|March 31, 2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapyMotoko Yamaguchi, Ritsuro Suzuki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in JapanMotoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, et al.
Hematological Oncology|February 10, 2022
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphomaKana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, et al.
Hematological Oncology|February 12, 2025
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational StudyYuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patientsTakashi Oyama, Kazuhito Yamamoto, Naoko Asano, et al.
Annals of Hematology|April 20, 2019
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal originMotoko Yamaguchi, Ritsuro Suzuki, Kana Miyazaki, et al.
Cancer|April 9, 2026
Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patientsKazutaka Suzuki, Kana Miyazaki, Naoko Asano, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Cancer Science|March 31, 2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapyMotoko Yamaguchi, Ritsuro Suzuki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in JapanMotoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, et al.
Hematological Oncology|February 10, 2022
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphomaKana Miyazaki, Ritsuro Suzuki, Masahiko Oguchi, et al.
Hematological Oncology|February 12, 2025
Treatments and Outcomes of Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational StudyYuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Pageof 13